McGill flags gray-market sourcing of BPC-157 and TB-500 'Wolverine' stack
The science office notes neither peptide is approved by Health Canada or the FDA, and that Canadian compounders route oral BPC-157 through a Natural Health Product loophole.
DO
By Daniel Okafor · Regulatory Correspondent
Sep 24 18:18 ETSource: McGill University
The wire
- 01McGill's Office for Science and Society writes that the self-injected 'Wolverine' stack of BPC-157 and TB-500 is unapproved in the US and Canada and usually bought from unmonitored Chinese producers.
- 02The piece notes Canadian doctors are referring patients to compounding pharmacies that treat oral BPC-157 as a Natural Health Product, and questions whether an oral version survives digestion.
- 03It also cites the recent FDA advisory panel vote favoring compounding of certain peptides, which is non-binding; the agency has yet to decide. This is commentary, not new data.
From the source
Read at mcgill.caBiohackers are Reaching for Wolverine Peptides
I must admit that I have never seen a “Wolverine” movie even though Hugh Jackman is one of my favourite performers. He was fantastic in the Broadway revival of The Music Man, excellent in The Greatest Showman and made a very good Jean Valjean in Les Miz. But now I’m going to have to watch at least one of the films in which he appears as “Wolverine” to see why that name has been hijacked by biohack
